Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 July 2020 | Story Andre Damons | Photo Supplied
Dr Champion N Nyoni.

As yet another testament to the great work being done, as well as the dedication, passion, and hard work of staff members in the School of Nursing at the University of the Free State (UFS), a senior lecturer became the first UFS staff member to win the prestigious Sigma Emerging Nurse Researcher/Scholar award – making him only the third African to win this award. 

“I was overwhelmed to be honoured with this award as the third African to have won it in the history of the awards. To me, this is an indication that the quality of our work in the School of Nursing is top-notch and meets international standards, and that our contribution to nursing science and nursing education is outstanding,” says a proud Dr Champion N. Nyoni on his latest achievement. 

Sigma Theta Tau International (Sigma) is a global honour society for nurses that recognises and advances nursing through research and scholarship. Membership for this society includes a minimum of a master’s qualification and nomination from current members based on your contribution and the potential thereof for nursing at a national and global scale. 

The Emerging Nurse Researcher/Scholar Award, with the purpose of recognising nurses whose research and scholarship has impacted the profession and the people it serves, was introduced in 2015.

No easy process 
It is quite a rigorous process to become eligible for the award, explains Dr Nyoni. “One is nominated by peers who are also part of Sigma; these peers must motivate their nomination by providing evidence related to the research and scholarship of the nominee.” 

“In addition to the numerous reference reports from colleagues in the discipline of nursing, additional referrals are sought from colleagues in other professions (in the health sciences) who have worked and engaged with the research of the nominee. This application process is then evaluated for consideration, among others, by a global panel. I never thought that I would win this award, given the nature of the nomination process, and the heavy funding that other nurse researchers globally receive in comparison to Africa,” says Dr Nyoni.

According to a passionate Dr Nyoni, the award will also give him the energy to continue an academic track, especially in nursing and nursing education, with a focus on improving the quality of nursing education, the quality of nursing graduates, impacting the nursing workforce and thereby influencing the quality of health indicators, especially in Africa, where health systems are nurse-driven. 

Dr Nyoni is appreciative of the nurturing environment and brilliant colleagues in the School of Nursing, who are supporting his research career.

Quality nursing education

"We need quality nurses for quality nursing care, and this should be done through quality nursing education. I hope to use this award as part of a motivation strategy for young nurses to be engaged in scholarship and in academia, as there is a great need, especially in sub-Saharan Africa,” concludes Dr Nyoni.

When he was nominated, Dr Nyoni had close to 15 publications in nursing education and close to 40 presentations at local and international conferences. He also had several awards for his research work, including the Best Education Paper: Senior Category at the Faculty of Health Science’s Research Forum in 2019. 

Dr Nyoni is currently a postdoctoral fellow (the first) in the UFS School of Nursing and serves as chairperson on several boards of directors relating to health professions education in the African region, namely AfrIPEN and SAFRI. He is also supervising several master’s and PhD students.
 
• This award will be presented on Thursday at the International Nursing Research Congress that is now taking place online due to COVID-19.

News Archive

Conference: Expanded ARV treatment
2005-03-02

VENUE: University of the Free State, Bloemfontein, South Africa
DATE: 30 March 2005 - 1 April 2005

  • ARV Programme as on 24Feb Download Word document
     
  • Programme Special events Download Word document


    Official web site www.fshealth.gov.za/subsites/arvc

     


    Rationale for the Conference
    At the time of the planned Conference, much ground would have been covered, both in the Free State and in South Africa, in respect of the expanded public sector ARV treatment programme in respect of research, experiences in practice, training of staff, treatment of patients, lessons learned, successes and failures, etc. The time would then be quite opportune to share these in a systematic manner with other provinces and countries, as well as with the large variety of stakeholders and role players in the ARV and related domains, be they academics and researchers, policy makers and service/facility managers, the variety of caregivers, and the community organisations and affected patients.

The Conference and current research
The proposed Conference is, firstly, directly linked to the current research on the public sector roll-out of ARV treatment in the Free State conducted by several research institutions (e.g. CIET, CHSR&D, UCT Lung Institute). Secondly, the Conference could and would serve as a forum for other research groups in the country and further a field to report and share knowledge and experiences on ARV treatment and related initiatives. Lastly, the Conference will stage a golden opportunity for researchers and scientists, on the one hand, and policy makers, managers, and caregivers (as knowledge users), on the other hand, to engage in cross-disciplinary discourse on this mutual and topical theme.

Theme of Conference
Expanded ARV treatment in the Free State: sharing experiences

Focus
The focus is primarily on public sector ARV treatment in the Free State, but also initiatives/activities/perspectives of relevance to the Free State elsewhere in the country at large and further a field, as well as relevant ARV initiatives in the public, private, NGO and FBO sectors. Bear in mind, however, that ARV treatment is but part of a much more comprehensive approach to HIV and AIDS. The Conference will, therefore, not narrowly focus on the ARV treatment programme only. The broader context, other relevant dimensions, and a comprehensive approach to the challenges of HIV, AIDS and TB are of equal importance.

The purpose of the Conference
Enhance meaningful exchange, mutual understanding and collaboration among researchers, scientists, policy makers, managers and practitioners in the field of ARV treatment and related fields.

Share experiences in the various spheres of ARV treatment and related spheres (policy, management, practice, research, training, public-private-civil society sectors).

Record, reflect and report on the establishment of the ARV treatment programme in the Free State, and in within the context of the comprehensive HIV/AIDS programme.

Disseminate important research results on ARV treatment and related themes to health policy makers, managers, practitioners, communities and to the research community.

Stimulate discourse among various disciplines and various stakeholders/role players involved in ARV treatment and related programmes.

Sensitise and acquaint researchers to the requirements of policy makers, managers and practitioners in respect of ARV treatment and related fields.

Facilitate the implementation of research results in ARV treatment policy, programmes and practice.

Dissemination of Conference-related information
Information generated during the Conference could feed into policy, management and practice of ARV treatment, the training accompanying such programme, and the existing body of knowledge. After the Conference the information will be disseminated via the Internet and by scientific and popular publications.

Date and duration
Set for 30 & 31 March & 1 April 2005; to commence at 09:00 on the first day (30 March) and to end at 16:30 (1 April) the third day.

Format and scope of Conference
Alternating plenary, parallel sessions and debates focused on topical issues and interest groups. The Conference will strive to be maximally interactive and participative.

Themes and topics to cover:

  • Policy, management and health services/practice (various levels and contexts – clinical treatment, information, IT systems, pharmacy, laboratories, nutrition)
     
  • Research covering all relevant disciplines and diverse dimensions of ARV treatment and related themes
  • Training and evaluation of training
  • Patients, communities and civil society organisations
  • Public, private, NGO, FBO initiatives and partnerships

Emphasis will be on the Free State, however, with of significant involvement from other provinces, SADC countries, and countries further a field. The thrust will be to export lessons and experiences from the Free State, but also to import lessons and experiences from other provinces, countries and sectors.

Presenters
Key presenters from the Free State, other provinces, South Africa, from the private, FBO and NGO sectors, and from several other countries

Delegates
About half of the delegates will be Free State stakeholders and role players (all levels and all contexts). The other half will be role players and stakeholders in the ARV and related fields from other provinces, the national level, and other countries, as well as from the private, public and non-governmental sectors.

Focused workshops
Provision will be made for half-a-day or one-day workshop initiatives on the third day (1 April 2005).

Enquiries
For more information please contact:

Prof Dingie van Rensburg
Centre for Health Systems Research & Development
University of the Free State
PO Box 339
Bloenfontein
SOUTH AFRICA
9300

Contact:
Carin van Vuuren
Conference Organiser
Centre for Health Systems Research & Development
University of the Free State
P.O.Box 339
Bloemfontein
South Africa
9300
Tel +27 (0) 51 401 2181
Fax +27 (0) 51 4480370
Cell 0832932890
e-mail: arvconference.hum@mail.uovs.ac.za

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept